Ensign Peak Advisors’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Sell |
371,857
-55,609
| -13% | -$2.05M | 0.02% | 400 |
|
|
2025
Q1 | $15.1M | Buy |
427,466
+122,294
| +40% | +$4.32M | 0.03% | 365 |
|
|
2024
Q4 | $13.3M | Buy |
305,172
+265,389
| +667% | +$11.6M | 0.02% | 397 |
|
|
2024
Q3 | $1.8M | Sell |
39,783
-229,721
| -85% | -$10.4M | ﹤0.01% | 994 |
|
|
2024
Q2 | $10.5M | Buy |
269,504
+229,721
| +577% | +$8.92M | 0.02% | 438 |
|
|
2024
Q1 | $1.28M | Sell |
39,783
-2,007
| -5% | -$64.7K | ﹤0.01% | 1157 |
|
|
2023
Q4 | $1.2M | Hold |
41,790
| – | – | ﹤0.01% | 1239 |
|
|
2023
Q3 | $1.16M | Hold |
41,790
| – | – | ﹤0.01% | 1084 |
|
|
2023
Q2 | $1.12M | Hold |
41,790
| – | – | ﹤0.01% | 1171 |
|
|
2023
Q1 | $905K | Hold |
41,790
| – | – | ﹤0.01% | 1325 |
|
|
2022
Q4 | $995K | Buy |
41,790
+27,150
| +185% | +$647K | ﹤0.01% | 1163 |
|
|
2022
Q3 | $289K | Buy |
14,640
+2,650
| +22% | +$52.3K | ﹤0.01% | 1719 |
|
|
2022
Q2 | $234K | Hold |
11,990
| – | – | ﹤0.01% | 1745 |
|
|
2022
Q1 | $306K | Buy |
11,990
+840
| +8% | +$21.4K | ﹤0.01% | 1743 |
|
|
2021
Q4 | $281K | Buy |
+11,150
| New | +$281K | ﹤0.01% | 1837 |
|
|
2021
Q2 | – | Sell |
-32,413
| Closed | -$1.49M | – | 1851 |
|
|
2021
Q1 | $1.49M | Hold |
32,413
| – | – | ﹤0.01% | 1252 |
|
|
2020
Q4 | $1.28M | Buy |
32,413
+7,265
| +29% | +$288K | ﹤0.01% | 1290 |
|
|
2020
Q3 | $875K | Buy |
+25,148
| New | +$875K | ﹤0.01% | 1356 |
|